BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 30230717)

  • 1. Descriptive epidemiology of cerebellar hypoplasia in the National Birth Defects Prevention Study.
    Howley MM; Keppler-Noreuil KM; Cunniff CM; Browne ML;
    Birth Defects Res; 2018 Nov; 110(19):1419-1432. PubMed ID: 30230717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maternal antihypertensive medication use and selected birth defects in the National Birth Defects Prevention Study.
    Fisher SC; Van Zutphen AR; Werler MM; Romitti PA; Cunniff C; Browne ML;
    Birth Defects Res; 2018 Nov; 110(19):1433-1442. PubMed ID: 30260586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific birth defects in pregnancies of women with diabetes: National Birth Defects Prevention Study, 1997-2011.
    Tinker SC; Gilboa SM; Moore CA; Waller DK; Simeone RM; Kim SY; Jamieson DJ; Botto LD; Reefhuis J;
    Am J Obstet Gynecol; 2020 Feb; 222(2):176.e1-176.e11. PubMed ID: 31454511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Descriptive and risk factor analysis of nonsyndromic sacral agenesis: National Birth Defects Prevention Study, 1997-2011.
    Nalbandyan M; Howley MM; Cunniff CM; Romitti PA; Browne ML;
    Am J Med Genet A; 2019 Sep; 179(9):1799-1814. PubMed ID: 31294918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyroid Medication Use and Birth Defects in the National Birth Defects Prevention Study.
    Howley MM; Fisher SC; Van Zutphen AR; Waller DK; Carmichael SL; Browne ML;
    Birth Defects Res; 2017 Nov; 109(18):1471-1481. PubMed ID: 28758357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maternal genitourinary infections and risk of birth defects in the National Birth Defects Prevention Study.
    Howley MM; Feldkamp ML; Papadopoulos EA; Fisher SC; Arnold KE; Browne ML;
    Birth Defects Res; 2018 Nov; 110(19):1443-1454. PubMed ID: 30402975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Next steps for birth defects research and prevention: The birth defects study to evaluate pregnancy exposures (BD-STEPS).
    Tinker SC; Carmichael SL; Anderka M; Browne ML; Caspers Conway KM; Meyer RE; Nembhard WN; Olney RS; Reefhuis J;
    Birth Defects Res A Clin Mol Teratol; 2015 Aug; 103(8):733-40. PubMed ID: 25846741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maternal occupation and the risk of birth defects: an overview from the National Birth Defects Prevention Study.
    Herdt-Losavio ML; Lin S; Chapman BR; Hooiveld M; Olshan A; Liu X; DePersis RD; Zhu J; Druschel CM
    Occup Environ Med; 2010 Jan; 67(1):58-66. PubMed ID: 20029025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for primary congenital glaucoma in the National Birth Defects Prevention Study.
    Forestieri NE; Desrosiers TA; Freedman SF; Aylsworth AS; Voltzke K; Olshan AF; Meyer RE;
    Am J Med Genet A; 2019 Sep; 179(9):1846-1856. PubMed ID: 31313509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sociodemographic, health behavioral, and clinical risk factors for anotia/microtia in a population-based case-control study.
    Ryan MA; Olshan AF; Canfield MA; Hoyt AT; Scheuerle AE; Carmichael SL; Shaw GM; Werler MM; Fisher SC; Desrosiers TA;
    Int J Pediatr Otorhinolaryngol; 2019 Jul; 122():18-26. PubMed ID: 30928866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternal autoimmune disease and birth defects in the National Birth Defects Prevention Study.
    Howley MM; Browne ML; Van Zutphen AR; Richardson SD; Blossom SJ; Broussard CS; Carmichael SL; Druschel CM;
    Birth Defects Res A Clin Mol Teratol; 2016 Nov; 106(11):950-962. PubMed ID: 27891777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of benzodiazepine medications during pregnancy and potential risk for birth defects, National Birth Defects Prevention Study, 1997-2011.
    Tinker SC; Reefhuis J; Bitsko RH; Gilboa SM; Mitchell AA; Tran EL; Werler MM; Broussard CS;
    Birth Defects Res; 2019 Jun; 111(10):613-620. PubMed ID: 30891943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasoactive exposures during pregnancy and risk of microtia.
    Van Bennekom CM; Mitchell AA; Moore CA; Werler MM;
    Birth Defects Res A Clin Mol Teratol; 2013 Jan; 97(1):53-9. PubMed ID: 23180593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations between maternal periconceptional exposure to secondhand tobacco smoke and major birth defects.
    Hoyt AT; Canfield MA; Romitti PA; Botto LD; Anderka MT; Krikov SV; Tarpey MK; Feldkamp ML
    Am J Obstet Gynecol; 2016 Nov; 215(5):613.e1-613.e11. PubMed ID: 27443814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laterality defects in the national birth defects prevention study (1998-2007): birth prevalence and descriptive epidemiology.
    Lin AE; Krikov S; Riehle-Colarusso T; Frías JL; Belmont J; Anderka M; Geva T; Getz KD; Botto LD;
    Am J Med Genet A; 2014 Oct; 164A(10):2581-91. PubMed ID: 25099286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential mechanisms of cerebellar hypoplasia in prematurity.
    Tam EW
    Neuroradiology; 2013 Sep; 55 Suppl 2():41-6. PubMed ID: 23842990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maternal caffeine intake and risk of selected birth defects in the National Birth Defects Prevention Study.
    Browne ML; Hoyt AT; Feldkamp ML; Rasmussen SA; Marshall EG; Druschel CM; Romitti PA
    Birth Defects Res A Clin Mol Teratol; 2011 Feb; 91(2):93-101. PubMed ID: 21254365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternal body mass index and lifestyle exposures and the risk of bilateral renal agenesis or hypoplasia: the National Birth Defects Prevention Study.
    Slickers JE; Olshan AF; Siega-Riz AM; Honein MA; Aylsworth AS;
    Am J Epidemiol; 2008 Dec; 168(11):1259-67. PubMed ID: 18835865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative analysis of perinatal outcomes and birth defects amongst adolescent and older Ugandan mothers: evidence from a hospital-based surveillance database.
    Serunjogi R; Barlow-Mosha L; Mumpe-Mwanja D; Williamson D; Valencia D; Tinker SC; Adler MR; Namale-Matovu J; Kalibbala D; Nankunda J; Nabunya E; Birabwa-Male D; Byamugisha J; Musoke P
    Reprod Health; 2021 Mar; 18(1):56. PubMed ID: 33663555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The National Birth Defects Prevention Study: A review of the methods.
    Reefhuis J; Gilboa SM; Anderka M; Browne ML; Feldkamp ML; Hobbs CA; Jenkins MM; Langlois PH; Newsome KB; Olshan AF; Romitti PA; Shapira SK; Shaw GM; Tinker SC; Honein MA;
    Birth Defects Res A Clin Mol Teratol; 2015 Aug; 103(8):656-69. PubMed ID: 26033852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.